REG - Shield Therapeutics - ACCRUFeR® Phase 3 pediatric trial published
RNS Number : 0572O Shield Therapeutics PLC 28 July 2026 Shield Therapeutics plc("Shield" or the "Company" or the "Group")ACCRUFeR® Phase 3 pediatric trial published in Pediatric DrugsClinically relevant positive effectiveness in pediatric trial (FORTIS)Results confirm safety and effectiveness o…